<PAGE> 1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
AMENDMENT NO. 1
TO
FORM 10-QSB
(X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period ended September 30, 1996
or
( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1933
Commission File No. 1-12848
CROWN LABORATORIES, INC.
(Name of small business issuer in its charter)
Delaware 75-2300995
(State of Incorporation) (I.R.S. Employer I.D. No.)
6780 Caballo Street
Las Vegas, Nevada 89119
(Address of Principal Executive Office)
(702) 696-9300
(Registrant's Telephone Number, Including Area Code)
Indicate by a check mark whether the registrant (1) has filed all the reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports) and (2) has been subject to such
filing requirements for the past 90 days. Yes _X_ No ____
The number of outstanding shares of the registrant's only class of common stock
as of September 30, 1996 Common Stock, $.001 par value -18,795,488
<PAGE> 2
CROWN LABORATORIES, INC.
Consolidated Statements of Operations
(UNAUDITED)
<TABLE>
<CAPTION>
For the three months ended For the nine months ended
September 30, 1996 September 30, 1995 September 30, 1996 September 30, 1995
------------------ ------------------ ------------------ ------------------
<S> <C> <C> <C> <C>
NET SALES $ - $ - $ - $ -
Cost of Sales - $ - - -
GROSS PROFIT - - - -
General and Administrative Expenses 1,151,137 1,064,050 3,063,913 2,531,445
----------- ----------- ----------- -----------
LOSS FROM OPERATIONS (1,151,137) (1,064,050) (3,063,913) (2,531,445)
Other Income/(Expense)
Other Income 25,200 - 75,600 -
Other Expense (119,783) (119,783)
Interest expense (64,998) (84,152) (154,541) (153,048)
Interest income 13,366 7,914 23,415 36,657
LOSS BEFORE INCOME TAXES (1,297,353) (1,140,288) (3,239,223) (2,647,835)
Income Tax Provision - - - -
----------- ----------- ----------- -----------
NET LOSS ($1,297,353) ($1,140,288) ($3,239,223) ($2,647,835)
=========== =========== =========== ===========
NET LOSS PER SHARE ($0.07) ($0.08) ($0.19) ($0.20)
=========== =========== =========== ===========
WEIGHTED AVERAGE NUMBER OF COMMON
AND COMMON EQUIVALENT SHARES
OUTSTANDING 17,833,920 13,760,727 16,833,920 13,124,891
=========== =========== =========== ===========
</TABLE>
The Accompanying Notes to the Consolidated Financial Statements are
an Integral Part of these Financial Statements
5
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CROWN LABORATORIES, INC.
Date: November 14, 1996 By: /s/ Craig E. Nash
----------------------------------
Craig E. Nash
Chief Executive Officer
Chairman, Board of Directors
By: /s/ Scott E. Hilley
----------------------------------
Scott E. Hilley
Vice President, Finance
